Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

An Unrivalled Speaker Line-up

We are currently pulling together the agenda and speaker list for 2018. If you would like to be part of the research or join the speaking list, please put forward your suggestions to anza@eyeforpharma.com

All Speakers



Isabelle Bocher-Pianka

Isabelle Bocher-Pianka

Chief Patient Affairs Officer, Ipsen

Read more

More information coming soon...

Veronica Foote

Veronica Foote

Head of Patient Relations & Communications Europe, Novartis Oncology Europe

Read more

More information coming soon...

Lode Dewulf

Lode Dewulf

Chief Patient Officer, Servier

Read more

More information coming soon...

Anders Lassen

Anders Lassen

Head of Regulatory Science & Advocacy, Lundbeck

Read more

Anders Blaedel Lassen is Director and Head of Regulatory Science & Advocacy at Lundbeck, a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. He is a strong advocate for improving patient and caregiver involvement in the research and development activities related to the medicines lifecycle. Mr. Lassen’s engagement in the field started during his previous position as scientific administrator at the European Medicines Agency (EMA) where he supported the Agency’s work with patients, consumers and healthcare professionals as part of the team developing interactions in the regulatory field with these stakeholders.

Mr Lassen has carried this interested into his present position, further developing Lundbeck’s partnerships with the patient community from a research and development perspective. Most recently, Mr Lassen has been nominated to represent Lundbeck in the Innovative Medicines Initiative PARADIGM (Patients Active in Research and Dialogues for an Improved Generation of Medicines).

Stefan Holmstrom

Stefan Holmstrom

Global Head, HTA Strategy, Astellas

Read more

More information coming soon...

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Daniel De Schryver

Daniel De Schryver

Patient Engagement and Advocacy Lead, Europe, Middle East and Africa, Janssen

Read more

Daniel De Schryver joined Johnson & Johnson in 2001 as Director Corporate Communications. In that function, he initially worked in the field of oncology. In 2006 he joined the Janssen teams working in Infectious Diseases where he helped to maintain and enhance the company’s relationships with the HIV Patient Community. Later, he built the external relationships in the field of Hepatitis C, before becoming the Global Therapeutic Area Communications Leader Infectious Diseases and Vaccines. In this function he developed world wide strategic communications and public affairs programs about infectious diseases and global public health.

Daniel has a Master in Romance Philology (Literature) and he started his career as a teacher.

After having worked in communications roles in the car industry for several years, he joined the non-profit sector and became country manager for Médecins Sans Frontières in Bosnia, Croatia and Angola. Back in Europe, he headed the Communications department for the organization. Before joining Johnson & Johnson, he worked at Burson-Marsteller as a consultant on corporate communications.

His personal interests are contemporary art and architecture, politics and meeting people.

Shahid Hanif

Shahid Hanif

Head of Health Data & Outcomes, ABPI

Read more

Shahid leads the ABPI’s health data and outcomes related activities. His role in the ABPI involves cross-functional working with our members, government bodies and relevant stakeholders and he represents our members externally on policy in these areas including implementation of the ABPI’s Big Data Road Map, the use of Real World Data and Evidence, activities relating to Precision Medicine, and outcomes-based health systems. Shahid leads WP3 (Communication and Outreach) of the Coordination and Support Action (DOIT) project of IMI2 BD4BO. Shahid holds a Doctorate in Molecular Biology, a Masters in Information Technology and Bachelors in Biochemistry from the University of Glasgow, with over ten years of experience in the industry working in R&D and Commercial functions.

Claire Baldwin

Claire Baldwin

Senior Director Marketing Excellence, Global Commercial Academy, AstraZeneca

Read more

Claire is a highly experienced international healthcare professional with demonstrable success in marketing, operational processes and capabilities for products, services and Patient Solutions. From strategic development to implementation and engagement of internal and external stakeholders Claire has extensive experience and leadership of complex matrix structures across multiple geographies.

Currently Claire is Senior Director Marketing Excellence, Global Commercial Academy at AstraZeneca responsible for managing the Global Marketing Excellence Programme to support building Marketing Excellence capability across the business.

Up until February 2017 Claire held the role of Director of Operations Europe and EU Liaison at Teva Pharmaceuticals responsible for the leadership and alignment of the Global Patient Solutions team with EU multidisciplinary teams. She built country PSP teams and managed the development and deployment of PSPs across multiple geographies in close collaboration with Regional and Country stakeholders whilst driving third party service provider selection, contracting and KPI monitoring

Richard Stephens

Richard Stephens

Consumer Lead and Chair of Consumer Forum, NCRI

Read more

Richard Stephens is a survivor of two cancers and a heart emergency, and has had multiple morbidities and late effects.

He Chairs the NCRI’s Consumer Forum and sits on NHS England's Cancer Patient Experience Advisory Group, as well as strategic groups for NIHR, NHS England, PHE-NCRAS, CQC, MRC CTU, Genomics England, Cancer Research UK, ABPI and others.

Richard was the patient representative on the Independent Cancer Taskforce that produced the (English) National Cancer Strategy, Achieving World Class Cancer Outcomes, and is a founder member of the AllTrials and useMYdata movements. He is joint Editor-in-Chief of BMC’s Journal of Research Involvement and Engagement.

He has worked with industry as an individual and with the NCRI Consumer Forum, and was influential in helping to shape both Cancer Research UK's Industry Partnerships and also the UK's NIHR-Industry Alliances to deliver industry studies in the NHS.

Carol Munt

Carol Munt

Patient Advocate

Read more

In 1982 Carol was a passenger involved in a road traffic accident in France, resulting in a fractured skull, brain haemorrhage and coma. On return to the UK she was diagnosed with Narcolepsy & Cataplexy as a result of the trauma .

Medication now keeps her condition fairly stable.

She is passionate about Patient & Public Involvement and co-production.

An Honorary Lecturer & Doubleday Affiliate at Manchester Medical School; she is also a member of HQIP Service User Network, Lay member of NHSE Always Events Advisory group, NIHR-NHSE Patient Experience Team, Kent & Medway STP Patient & Public Advisory Group and Social Workforce programme, and recently DeepMind Health Users Group.

She is a Q community member and remains one of HSJ’s Top 50 Patient Leaders.

She is a confident, entertaining and well received public speaker recently addressing audiences at the King's Fund, IHI/BMJ, ADASS/NHS, HC-UK, Westminster Health Forum, NHS South CSU, and the Futures Stage at Expo 2017 amongst others.

Until her move to Kent last year Carol was Co-chair of NHS Thames Valley Patient Experience Operational Group and part of the team for the Leading Together programme.

She worked closely with Health Education Thames Valley on the e-version of the Dementia Handbook for Carers and Care Providers’ having been part of the team behind the original printed version.

She lives in Tunbridge Wells, Kent.

munt12@aol.com twitter @muntma

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Tim Scrivener

Tim Scrivener

Solution Architect and Data Scientist, AstraZeneca

Read more

A career IT professional specialising in complex and high-performance computing environments with an extensive background in technical consultancy, data analytics and full-lifecycle systems engineering. I joined AstraZeneca in 2015, following a long career in development of research and operational solutions in defence and commercial domains. With AstraZeneca I wanted to focus on the design and development of analytics and systems to support early clinical development, with a strong emphasis on machine learning and data-driven decision support. It is a calling which has provided many hugely absorbing opportunities to work closely with passionate, expert colleagues to positively influence the patient experience.

Jeremy Taylor

Jeremy Taylor

Patient Advocate

Read more

Jeremy Taylor has been chief executive of National Voices since 2009. The national coalition of health and care charities in England has grown under his direction as a leading, independent champion for patients, carers and the voluntary sector.

Jeremy provides a strategic voice on person centred care, the engagement of citizens in decisions about health, and the role of the voluntary and community sector. He acts as an expert advisor, writer, commentator, media spokesman, conference speaker and facilitator of leadership development.

In 2017 he was included for the 7th year running in the Health Service Journal annual list of 100 people with the greatest influence in health.

Jeremy joined the voluntary sector in 2007 and was previously a senior official at HM Treasury.

Isabel Torres

Isabel Torres

Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada, Takeda

Read more

More information coming soon...

Jenny Royle

Jenny Royle

Patient-centricity Program Lead, digitalECMT, Cancer Research UK and The Christie NHS Foundation Trust

Read more

After finishing my PhD in Pharmacology at the University of Cambridge, I moved into the Pharmaceutical industry. There I spent many years working at all steps of clinical development, from the first use of a drug in people, through to monitoring safety after a drug is authorized for general use. I have expertise in a wide range of disciplines including clinical science, regulatory affairs, data visualization and analysis, risk monitoring and management strategy, and patient-focused research. I’m now in the digital Experimental Cancer Medicine Team (digitalECMT) for Cancer Research UK, Manchester Institute, and The Christie NHS Foundation trust. Our mission is to innovate and apply digital science to transform decision-making in early clinical trials and the patient's role. I lead the projects focusing on patients and their loved ones. Aiming to ensure that they have the choice to be an active contributor and partner in their own care, as well as a ‘co-scientist’ in new and innovative research. I’m always looking to develop new and innovative approaches to ensure we deliver this vision.

Stephen Rea

Stephen Rea

Vice President and Head of External Affairs and Communications, ViiV Healthcare

Read more

More information coming soon...

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Sanja Njegic

Sanja Njegic

Head of Patient Advocacy and Integrated Care Strategy, Europe and Canada, Takeda

Read more

More information coming soon...

Christoph Thalheim

Christoph Thalheim

Director External Affairs, European Multiple Sclerosis Platform (EMSP)

Read more

More information coming soon...

Christina Donatti

Christina Donatti

IMI Lead, Real World Evidence, Janssen

Read more

More information coming soon...

Teresa Ferreiro

Teresa Ferreiro

Patient Advocate

Read more

Teresa is a certified professional coach, cancer survivor, business facilitator and speaker. From her breast cancer experience (36), she learned that patients need to be empowered so they can take control of their lives. Health care professionals are a key entry point to achieve this goal. She applies coaching and personal development training with them and with patients for this

Vanessa Pott

Vanessa Pott

Director, Patient Advocacy & Strategic Partnerships, Global Healthcare Government & Public Affairs, Merck Group

Read more

More information coming soon...

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Chenglong Han, MD, PhD

Chenglong Han, MD, PhD

Director, Patient-Reported Outcomes, Global Market Access, Janssen

Read more

Chenglong Han, PhD, MD, is a Director in the global market access and patient-reported outcomes group in the Janssen Pharmaceutical Companies of Johnson & Johnson, supporting new drug development in the immunology area, for more than 18 years. Chenglong co-authored more than 40+ research papers in the peer-reviewed journals and presented numerous posters in scientific conferences in health economics and outcomes research field. Before Joined Janssen, Chenglong was a post-doctoral fellow in the National Institutes of Health (NIH) and conducted researches in molecular epidemiology, virology and the relationship of Human Papilloma Virus (HPV) infection and risk of cancer. Chenglong has a PhD in epidemiology and MD in preventive medicine.

Geoff Rollason

Geoff Rollason

Patient Experience and Service Director - Oncology UK, Pfizer

Read more

More information coming soon...

David Yeandle, OBE

David Yeandle, OBE

Member, MS in the 21st Century Patient Steering Group

Read more

David was diagnosed with relapsing remitting MS in 2010, having experienced symptoms up to 3 years prior to this. While many people find an MS diagnosis a difficult and confusing time due to a lack of general awareness around the disease, David was unfortunately all too familiar with MS, having seen his sister diagnosed with the disease almost 30 years previously. Using his existing knowledge and experience of MS, David decided to approach his diagnosis with a positive attitude and the motto ‘I will manage my MS rather than allow it to manage me’; while his illness did eventually force him to take early retirement from his demanding job as Head of Employment for an organisation representing the UK’s manufacturing industry, he has since flourished as a part time consultant performing a variety of roles, including serving as the President of the United Nations’ Staff-Management Committee. David is a new addition to the MS in the 21st Century Steering Group having joined in July 2017 and as a result of his own experiences and expertise is a passionate advocate of helping MS patients to stay in employment.

Lise Pape

Lise Pape

Carer & Founder, Walk with Path

Read more

Lise Pape is the Founder of Walk With Path and in charge of business development, strategy and partnership. Lise holds a BSc in Human Biology from King’s College London and a double masters MA/MSc in Innovation Design Engineering from Imperial College London and the Royal College of Art. In addition, Lise has worked in finance for J.P. Morgan, where she held roles in Product Management, Network Management, and was responsible for client and stakeholder relationships internally and externally. She has also worked in advertising for AOL's Advertising.com, where she was a Delivery Manager responsible for the Nordic region. Additionally, Lise has worked as Investment Manager at the Ministry of Foreign Affairs of Denmark at the Royal Danish Embassy in London, where she was responsible for job creation into Denmark within life sciences and clean technologies. 

Lise founded Walk With Path in 2014, based on her developments during Innovation Design Engineering, and her personal experience with Parkinson’s suffered by her father. The company launched it's first product in 2017; Path Finder, a visual cueing shoe attachement to help those with Parkinson's. The second product, a haptic feedback insole to improve balance; Path Feel, is in development. 

Ben Harman Jones

Ben Harman Jones

HCP

Read more

After qualifying in medicine with honours, Ben worked as an acute doctor before moving into health communications, where he develops innovative ways to improve the lives of patients and health professionals. He spends around half his time practicing in psychiatry, where he pursues his passion for holistic mental care for patients with physical health problems.

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Dom Raban

Dom Raban

Founder, Xploro

Read more

Dom Raban has been creating ‘stuff’ for nearly 40 years, from punk fanzines in the 1970s to content for emerging technology platforms now. He’s been in the digital space since the start, building his first website in 1995 and his first 3D virtual environment in 1996. His current agency, Corporation Pop, was launched in 2007 and was one of only 35 companies worldwide to be accredited as Gold Solution Providers for Second Life. In those heady days of virtual worlds they delivered several ground-breaking corporate and educational projects for clients including EMI, BP, the NHS and Manchester Business School.

Since 2010 they have focused on Unity 3D development and have built immersive virtual environments for all sorts of use cases, from connected TV applications to avatar-based software that helps young people with mental health issues. For the last three years they have focused on bringing their experience with immersive 3D spaces to virtual and augmented reality.

Currently they are working on several AR, AI and VR projects including ‘Xploro’, an app for child patients that helps reduce the stress associated with hospitalisation by increasing familiarisation with staff, environments and procedures.

Dom is an awarded member of D&AD and a member of the VRARA Digital Health Committee.

Lisa Mackenzie

Lisa Mackenzie

Patient Advocate

Read more

My name is Lisa Mackenzie I live in Cheshire, I have a family history of Ill health and I’ve lived with my own since I was a teenager, although I didn’t realise it at the time. I have Bipolar - rapid cycling, Depression, anxiety & have suffered with eating disorders (Anorexia, Bulimia, & binge eating disorder) I have been on lots of medication over the years, had lots of counselling & I see a psychiatrist on a regular basis, I also study mindfulness. I am a single parent of two sons a Beauty Therapist, a dog walker and I’m currently studying Art at college. I feel happy & in a good place right now.

Emma Lawton

Emma Lawton

Devices Apps & Gadgets Strategist, Parkinsons UK

Read more

More information coming soon...

Kenza Seddik

Kenza Seddik

Patient Experience and Value Lead , UCB

Read more

More information coming soon...

Boglarka Szegvari

Boglarka Szegvari

Global Head of Access Strategy for non-drug solutions and populations, UCB

Read more

More information coming soon...

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Andrew Warrington

Andrew Warrington

Patient

Read more

For over 35 years, Andrew Warrington has been told that a cure to type 1 diabetes cannot be more than 10 years away. While academia and pharma continue to work on finding a cure, Andrew decided in 2015 he is unable to wait any longer for current treatments to deliver better outcomes. He decided to take matters into his own hands.

Trishna Bharadia

Trishna Bharadia

Patient Advocate, eyeforpharma Award Winner

Read more

Trishna Bharadia is a multi-award winning patient advocate for chronic illness, hidden disability and multiple sclerosis. She was diagnosed with MS in 2008 and despite having a full time job as a translator, uses her spare time to work with various stakeholders, including pharma, clinicians and the third sector, to improve support, services and patient engagement in the healthcare arena. In 2015, she put MS on the national map when she was chosen to feature in a special four-part edition of Strictly Come Dancing. It was aired on BBC1 and she was chosen specifically because of her advocacy work and her approach to the MS diagnosis. She’s a vlogger, writer and sought-after speaker, as well as advising on projects, research proposals and diversity strategies, and is regular contributor in the media for health-related issues. She’s also a patron/ambassador for several charities and is the current holder of the EyeforPharma Patient Advocate (Europe) Award. TWITTER: @TrishnaBharadia

Pedro Oliveira

Pedro Oliveira

Founder and President, Patient Innovation

Read more

Pedro Oliveira is Professor at Copenhagen Business School with special responsibilities in healthcare innovation; He is also Academic Fellow at the Cornell Institute for Healthy Futures at Cornell University; Founder and President of Patient Innovation; and co-founder of PPL Crowdfunding. Pedro is Principal Investigator of several research initiatives.

Previously he was a Professor at Católica-Lisbon School of Business and Economics, where, among other, he served as Senior Associate Dean for Faculty and Research, Academic Director of the Lisbon MBA, and Director of the doctoral program in Technology Change and Entrepreneurship. He was also an International Faculty Fellow at MIT Sloan School of Management and Advisor to the Ministry of Science, Technology and Higher Education.

He received his Ph.D. in Operations, Technology and Innovation Management from the University of North Carolina at Chapel Hill; hisM.Sc. in Operations Research and Systems Engineering; and his 'licenciatura' in Naval Engineering from Instituto Superior Técnico. He also completed some advanced training at Harvard Business School and Northwestern University’s Kellogg School of Management.

Niklas Hedberg

Niklas Hedberg

Chair of Executive Board, EUnetHTA

Read more

Niklas Hedberg is the Chief Pharmacist at the governmental authority, the Dental and Pharmaceuticals Benefits Agency (TLV), in Sweden.

Since May 2018, Niklas is the Chair of the EUnetHTA Executive Board. He has been a member of the Executive Board and the TLV lead partner in EUnetHTA, leading WP 3 – Evaluation since June 2016.

Niklas has been involved in the national pricing and reimbursement decision making for pharmaceutical products since 2001 and for medical devices since 2009. He has a broad experience of different aspects of value based evaluation. Since 2009 Niklas has had a special interest in joint scientific advice.

Between August 2009 and March 2014 Niklas was the Head of Department in the Department for Pharmaceutical Submissions at TLV. Before that he held positions as investigator, medical assessor and project leader in the agency.

Before entering the TLV in 2001 Niklas worked a couple of years as a sales representative within the pharmaceutical industry.

Carole Sian Scrafton MBS, BA (hons)

Carole Sian Scrafton MBS, BA (hons)

Patient Advocate

Read more
  • Disabled
  • Health and Patient advocate, ambassador, for all things related to chronic /invisible illnesses, volunteer
  • Co-founder and Founding Five member of Fibro Flutters
  • Fibro Flutters Group Co-ordinator and social media & events co-ordinator Volunteer Admin helping to share as much up to date information via varying social media platforms while supporting people with Fibromyalgia, Me/CFS, Chronic illness, Chronic Pain, EDS/HMS, Mental Health & other invisible illness.
  • Studied Global, Corporate and General Business Management | MBS | University of Sunderland
  • Studied Glass & Ceramics at University of Sunderland | BA (hons)
  • I love socialising, theatre & travelling, gaming and messing with art, photography, 3D Paint and phototastic

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Doris Christiane Schmitt

Doris Christiane Schmitt

Consulting and Training, Doctor-Patient-Communication

Read more

Since 1999 I am proud to have fought breast cancer successfully. As a breast cancer survivor, the last 18 years have thought me much about the science and the psychology of breast cancer. The motivation all over the planet to eradicate this disease is impressive, however not enough has been done yet. Early detection and the successful treatment of breast cancer are essential for the survival of a breast cancer patient. Advanced and metastatic breast cancer on the other hand has to be seen as a different disease than early stage breast cancer. Surveys have shown that women with metastatic breast cancer do not get the attention they need. Therefore it is vital raising awareness in public and policy makers what this highly vulnerable group and their families need in order to deal with the disease with best quality of life.

Patient information and counseling are the basis for successful treatment compliance and quality of life. Equally important the doctor must be informed by the patient to understand patient’s aims as well as justified and unjustified concerns. The mechanism of this communication is an understudied area of research. Miscommunication can lead to suboptimal treatment, low participation in screening or a slow recruitment to clinical studies. Especially in the preventive situation, informing women at high risk is a challenging task and might be crucial for the success of a drug prevention study. My expectations for the upcoming projects are the integration of aims that truly match the best scientific rationale and genuine patients’ expectations.

Christina Claussen

Christina Claussen

Director Alliance Management & Patient Relations for Corporate Affairs, Pfizer

Read more

Christina Claussen is Director Alliance Management & Patient Relations for Corporate Affairs Pfizer Germany, additionally leading Patient Relations for Pfizer Oncology/breast cancer in International Developed Markets. She holds a master in politics/economics/administration sciences (University of Konstanz) and worked for a German sick fund and the Federal German Pharmacists Association, before she joined Pfizer in 2002. Since then, she has built a Patient Relations Competence Center initiating projects and alliances with patient organizations in co-creation across all functions of the company, including all businesses, regulatory affairs and clinical trials. She is member of the EUPATI Germany core team and leading the German PhRMA/Local Area Working Group for Patient Affairs since 2006.

Paola Antonini, MD, PhD

Paola Antonini, MD, PhD

AISC Scientific Committee Member, Head of Clinical Research & Training Initiatives, AISC

Read more

Dr Antonini received her M.D. from the University of Rome “La Sapienza” Magna Cum Laude, with Top Honors in all examinations. She has a PhD in Clinical Pharmacology. In more than 30 years of experience in Pharma Industry Dr Antonini has played a key role in many successful programs of drug development, capitalizing on her scientific leadership and on-the-job experience in the designing, implementation and interpretation of clinical trials. Among Dr Antonini’ accomplishments are a substantial contribution to the clinical development of a number of products in the cardiovascular, internal medicine, metabolism, respiratory, oncology and neuroscience area. Dr Antonini has established valuable relationships and collaborations with many key scientific leaders in a number of therapeutic areas and this allowed her to build an innovative, strong partnership with Italian and International Academia in the field of Clinical Research. As a peer interlocutor of Academy members Dr Antonini has been invited to be Lecturer at Master in Clinical Research organized by the Universities of Florence, Ferrara, Rome (Catholic University , University of Tor Vergata and University of Roma3), and Chieti. She authored several peer-reviewed articles and has been invited as speaker in International and National events in the areas of Pharmaceutical Medicine, Methodology of clinical trials and Pharmacology. In 2018 she joined AISC where she serves as Member of AISC Scientific Committee and Head of Clinical Research & Training Initiatives.

Patient Leaders



Steering Board #impatientconf



Erin Moriarty Wade

Erin Moriarty Wade

Rare Disease Carer

Read more

I’m a freelance writer specializing in healthcare. With nearly 20 years of experience, my work has appeared in publications ranging from Atlanta Business Chronicle to Phnom Penh Post and the San Francisco Chronicle. I also do content writing for businesses, and I have done extensive work for hospital websites. As the mom of a child with a rare disease, I am especially passionate about the patient experience. I have a unique perspective as a long-time health writer who found myself unexpectedly navigating a complex disease when my daughter became sick.

I am a graduate of American University’s School of International Service in Washington, D.C., and I earned a master’s degree in journalism from Columbia University in New York City.

Matt Eagles

Matt Eagles

Patient & Patient Advocate

Read more

I have lived with Parkinson’s for 42 years. My passion is raising awareness of patient sentiment, encouraging meaningful dialogue between pharma, HCPs and patients themselves, so outcomes benefit everyone. I have spoken at Wired Health 2017, Financial Times HealthTech Europe, Digital World Health Summit and The British Neuroscience Winter Symposium, Founders Forum, Mindshare Huddle and the Virtual Futures salon. I go by the mantra: ‘never pre-judge and never discount opinion without listening first , everyone has a story to tell and something valuable to contribute if you let them.‘

Margot Vanfleteren

Margot Vanfleteren

Patient Advocate

Read more

Throughout the years I've attended various congresses and other pharma-oriented events. Each time it struck me how people talked about patients and aimed to improve patient experience without including patients. For that reason I've tried to advocate for patient inclusion at conferences and in pharma events. The concept of im-patient aligns with my values and vision for healthcare. Being able to make a succes out of the im-patient conference together with other patients would be amazing!

Simon Stones

Simon Stones

Patient Advocate

Read more

I am a young person with direct experience as a patient with multiple chronic conditions and as a carer. I'm also a vocal advocate on a national and international level for people with musculoskeletal conditions, speaking up for better care and support. I have experience of working at board level on two charities, and have worked and continue to work with industry in a consultancy capacity to better involve patients in research and innovation.

Cecile Tardy-Srinivasan

Cecile Tardy-Srinivasan

Patient Advocate

Read more

More information coming soon...

Richard Stephens

Richard Stephens

Patient Carer

Read more

More information coming soon...

Inês Alves

Inês Alves

Patient Advocate & Carer

Read more

More information coming soon...

Speakers



Lise Pape

Lise Pape

Carer & Founder, Walk with Path

Read more

Lise Pape is the Founder of Walk With Path and in charge of business development, strategy and partnership. Lise holds a BSc in Human Biology from King’s College London and a double masters MA/MSc in Innovation Design Engineering from Imperial College London and the Royal College of Art. In addition, Lise has worked in finance for J.P. Morgan, where she held roles in Product Management, Network Management, and was responsible for client and stakeholder relationships internally and externally. She has also worked in advertising for AOL's Advertising.com, where she was a Delivery Manager responsible for the Nordic region. Additionally, Lise has worked as Investment Manager at the Ministry of Foreign Affairs of Denmark at the Royal Danish Embassy in London, where she was responsible for job creation into Denmark within life sciences and clean technologies. 

Lise founded Walk With Path in 2014, based on her developments during Innovation Design Engineering, and her personal experience with Parkinson’s suffered by her father. The company launched it's first product in 2017; Path Finder, a visual cueing shoe attachement to help those with Parkinson's. The second product, a haptic feedback insole to improve balance; Path Feel, is in development. 

Ben Harman Jones

Ben Harman Jones

HCP

Read more

After qualifying in medicine with honours, Ben worked as an acute doctor before moving into health communications, where he develops innovative ways to improve the lives of patients and health professionals. He spends around half his time practicing in psychiatry, where he pursues his passion for holistic mental care for patients with physical health problems.

Dom Raban

Dom Raban

Founder, Xploro

Read more

Dom Raban has been creating ‘stuff’ for nearly 40 years, from punk fanzines in the 1970s to content for emerging technology platforms now. He’s been in the digital space since the start, building his first website in 1995 and his first 3D virtual environment in 1996. His current agency, Corporation Pop, was launched in 2007 and was one of only 35 companies worldwide to be accredited as Gold Solution Providers for Second Life. In those heady days of virtual worlds they delivered several ground-breaking corporate and educational projects for clients including EMI, BP, the NHS and Manchester Business School.

Since 2010 they have focused on Unity 3D development and have built immersive virtual environments for all sorts of use cases, from connected TV applications to avatar-based software that helps young people with mental health issues. For the last three years they have focused on bringing their experience with immersive 3D spaces to virtual and augmented reality.

Currently they are working on several AR, AI and VR projects including ‘Xploro’, an app for child patients that helps reduce the stress associated with hospitalisation by increasing familiarisation with staff, environments and procedures.

Dom is an awarded member of D&AD and a member of the VRARA Digital Health Committee.

Lisa Mackenzie

Lisa Mackenzie

Patient Advocate

Read more

My name is Lisa Mackenzie I live in Cheshire, I have a family history of Ill health and I’ve lived with my own since I was a teenager, although I didn’t realise it at the time. I have Bipolar - rapid cycling, Depression, anxiety & have suffered with eating disorders (Anorexia, Bulimia, & binge eating disorder) I have been on lots of medication over the years, had lots of counselling & I see a psychiatrist on a regular basis, I also study mindfulness. I am a single parent of two sons a Beauty Therapist, a dog walker and I’m currently studying Art at college. I feel happy & in a good place right now.

Emma Lawton

Emma Lawton

Devices Apps & Gadgets Strategist, Parkinsons UK

Read more

More information coming soon...

Andrew Warrington

Andrew Warrington

Patient

Read more

For over 35 years, Andrew Warrington has been told that a cure to type 1 diabetes cannot be more than 10 years away. While academia and pharma continue to work on finding a cure, Andrew decided in 2015 he is unable to wait any longer for current treatments to deliver better outcomes. He decided to take matters into his own hands.

Pedro Oliveira

Pedro Oliveira

Founder and President, Patient Innovation

Read more

Pedro Oliveira is Professor at Copenhagen Business School with special responsibilities in healthcare innovation; He is also Academic Fellow at the Cornell Institute for Healthy Futures at Cornell University; Founder and President of Patient Innovation; and co-founder of PPL Crowdfunding. Pedro is Principal Investigator of several research initiatives.

Previously he was a Professor at Católica-Lisbon School of Business and Economics, where, among other, he served as Senior Associate Dean for Faculty and Research, Academic Director of the Lisbon MBA, and Director of the doctoral program in Technology Change and Entrepreneurship. He was also an International Faculty Fellow at MIT Sloan School of Management and Advisor to the Ministry of Science, Technology and Higher Education.

He received his Ph.D. in Operations, Technology and Innovation Management from the University of North Carolina at Chapel Hill; hisM.Sc. in Operations Research and Systems Engineering; and his 'licenciatura' in Naval Engineering from Instituto Superior Técnico. He also completed some advanced training at Harvard Business School and Northwestern University’s Kellogg School of Management.

Download the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown